| 000 | 03019nam a22003855i 4500 | ||
|---|---|---|---|
| 999 |
_c75900 _d75900 _x1 |
||
| 001 | 75900 | ||
| 003 | ES-MaUEC | ||
| 005 | 20230207040202.0 | ||
| 006 | a||||fo|||| 00| 0 | ||
| 007 | cr nn 008mamaa | ||
| 008 | 121206s2013 xxu| s |||| 0|eng d | ||
| 020 | _a9781461452607 | ||
| 024 | 7 |
_a10.1007/978-1-4614-5260-7 _2doi |
|
| 040 |
_bspa _cES-MaUEC _dES-MaUEC |
||
| 050 | 4 |
_aRC280.B6 _bA382 2013 EB |
|
| 245 | 0 | 0 |
_aAdvances in Biology and Therapy of Multiple Myeloma _nVolume 2, _pTranslational and Clinical Research _cedited by Nikhil C. Munshi, Kenneth C. Anderson |
| 260 |
_aNew York _bSpringer International Publishing _c2013 |
||
| 300 |
_a1 recurso en línea (X, 287 p.) _b7 ilustraciones, 5 ilustraciones en color |
||
| 336 |
_aTexto (visual) _btxt _2rdacontent |
||
| 337 |
_aelectrónico _bc _2rdamedia |
||
| 338 |
_arecurso electrónico _bcr _2rdacarrier |
||
| 505 | 0 | _aT cell responses in myeloma -- Novel antigenic targets for immunotherapy in myeloma -- Antibody-based therapies in Multiple Myeloma -- Defining multiple myeloma as a target for DNA gene fusion vaccines -- Harnessing allogeneic immunity for anti-myeloma response -- Dendritic cell and peptide-based vaccination in myeloma -- New Proteasome inhibitors -- Newer Imids -- New agents in myeloma -- Early Combination Studies in MM -- The effect of novel antimyeloma agents on bone metabolism -- Index. | |
| 520 | 3 | _aDespite the advances in conventional, and novel agent and high dose chemotherapy, multiple myeloma remains incurable. In order to overcome resistance to current therapies and improve patient outcome, novel biologically-based treatment approaches are being developed. Current translational research in multiple myeloma focusing on the development of molecularly-based novel targeted single-agent and combination therapies has great promise to achieve high frequency and durable responses in the majority of patients. This volume will focus on biology of multiple myeloma, especially on oncogenomic changes, cell signaling pathways and intermediate molecules that are being investigated for development of novel therapies. The book will present newer developments, providing an emphasis on basic science, as well as its significant clinical impact. | |
| 988 | _aEBOOK, EBSPRINGERrevisado | ||
| 650 | 7 |
_aHuesos _xTumores _9182468 _0comprobar BNE19901362136 _2embne |
|
| 650 | 7 |
_aMieloma múltiple _0comprobar BNE20021387571 _2embne _9160182 |
|
| 700 | 1 |
_aAnderson, Kenneth C _eeditor literario _946459 |
|
| 700 | 1 |
_aMunshi, Nikhil C. _eeditor literario _984566 _0Local |
|
| 856 | 4 | 0 |
_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://link.springer.com/book/10.1007/978-1-4614-5260-7 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid) |
| 907 |
_a.b12815184 _b10-10-17 _c01-10-14 |
||
| 942 |
_2lcc _cLE |
||
| 945 |
_aRC280 .B6 A382 2013 EB _cV. 2 _g1 _ieBOOK _j0 _lmae _o- _pEUR0.00 _q- _r- _sb _t15 _u0 _v0 _w0 _x0 _y.i11544569 _z06-04-17 |
||
| 998 |
_dz _ea _feng _gxxu _h0 |
||